InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Hively Brad, Chief Executive Officer. Insider active across 1 companies, notably Oncology Institute, Inc.. Cumulatively, 5 reports have been logged. The latest transaction was disclosed on 21 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
0108,469 shares0
Common stock
SEC:0001628280-22-007101:0·
0141,380 shares0
Common Stock
SEC:0001104659-21-141460·
0141,380 shares0
Common Stock
SEC:0001104659-21-141460:0·
0141,380 shares0
Common Stock
SEC:0001104659-21-140219·
0141,380 shares0
Common Stock
SEC:0001104659-21-140219:0·
5 of 5 declarations
About Hively Brad
Brad Hively is the Chief Executive Officer of Oncology Institute, Inc. He leads the company with a focus on innovation and improving patient care. His leadership is essential for the mission and objectives of Oncology Institute.
